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Post-translational modiﬁcations (PTMs) occur on nearly all proteins. Many domains within proteins
are modiﬁed on multiple amino acid sidechains by diverse enzymes to create a myriad of possible
protein species. How these combinations of PTMs lead to distinct biological outcomes is only begin-
ning to be understood. This manuscript highlights several examples of combinatorial PTMs in pro-
teins, and describes recent technological developments, which are driving our ability to understand
how PTM patterns may ‘‘code’’ for biological outcomes.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Patterns, signatures, and codes
Most proteins are post-translationally regulated in some man-
ner by enzymes that directly alter the chemical makeup of the pro-
tein. These enzymes can be proteases, transferases (kinases,
acetyltransferases, methyltransferases, glycosyltransferases, etc.),
or enzymes that remove groups (phosphatases, deacetylases, gly-
cosidases, etc.). In all, more than 400 discrete types of modiﬁca-
tions can occur and, to date, more than 90000 individual PTMs
have been identiﬁed through biochemical and biophysical analysis
[1]. PTMs are known to act alone and in combination to regulate
nearly all aspects of protein function. Thus, deciphering how PTMs
are coordinately regulated is of fundamental importance to our
understanding of biology.
While many proteins are known to be heavily modiﬁed, combi-
natorial PTMs have perhaps been best studied in the context of his-
tones, where, more than ten years ago, Strahl and Allis proposed
that PTMs on the tails of histone proteins, alone or in combination,
specify downstream events [2]. The original paper talks about a
language of histone modiﬁcations, but today these concepts are
generally referred to as the ‘‘histone code hypothesis’’ [2]. In the
intervening years, several signiﬁcant events have occurred. Tre-
mendous technological advances have been made, allowing us toidentify numerous histone PTMs, the enzymes responsible for
transferring and removing many PTMs, and a host of protein do-
mains that recognize speciﬁc histone PTMs. Improvements in mass
spectrometry and proteomics techniques have also revolutionized
the rate and detail with which PTMs are identiﬁed within the pro-
teome. Consequently, there is great interest in identifying addi-
tional codes that modulate protein function [3–5]. Likewise,
interdependences between PTMs within distant regions of the
same protein, or on different proteins within complexes, are now
commonplace. Thus, there is a nearly constant re-examination of
how we deﬁne the interrelationships of multiple PTMs.
Among researchers interested in PTM biology, there is often de-
bate over the nomenclature used to describe how the multitude of
PTMs on a given protein regulates function. Currently, our capacity
to detect PTMs far exceeds our ability to understand their biologi-
cal function. This unfortunate, but important distinction is at the
root of the controversy underlying the use of the term ‘‘code’’ to re-
fer to patterns of PTMs that are ‘‘read’’ by the cell to drive biological
outcomes. A general set of principles to decipher these codes has
not yet emerged, and consequently many ﬁnd the term ‘‘code’’ mis-
leading. Whether they are called ‘‘codes’’ or not, we can clearly
state that: (1) Many proteins have regions within their primary se-
quence that are targets for extensive, and often overlapping, mod-
iﬁcation by enzymes; (2) In many cases, these PTMs can recruit the
binding or modulate the activity of other proteins; (3) Patterns of
PTMs can be identiﬁed that correlate with differential biological
states (e.g. normal or disease states, cell cycle stage, aging)
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Fig. 1. Combinatorial PTMs can code for complex biological outcomes. (A) Modiﬁcations such as methylation (red), phosphorylation (yellow), or acetylation (blue) are
commonly recognized by proteins with PTM-recognition domains (purple and cyan). Modiﬁcations such as lysine methylation can occur up to three times on a single residue
resulting in PTMs with distinct activity. (B) Neighboring PTMs have differing effects on the ability of proteins to recognize a phosphorlyation site. For example, the purple
protein requires dimethylation of the lysine, but is occluded by trimethylysine and uninﬂuenced by the neighboring acetylation. In contrast, the cyan protein can be blocked
by aceylation but is uneffected by methylation. (C) The combinatorial PTMs setup a ‘‘code,’’ that determines which protein–protein interactions lead to distinct biological
outcomes.
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the complex biology of PTMs, and the growing evidence demon-
strating that the interactions of modiﬁcations that exist across a
landscape of proteins act concomitantly to orchestrate complex
biological outcomes.
2. Combinatorial PTMs coordinate protein–protein interactions
– lessons from histone tails
DNA is packaged around two copies each of four histones (H2A,
H2B, H3, and H4) to form nucleosomes, the basic unit of chromatin
structure. Nucleosomes play pivotal roles in compacting the gen-
ome and protecting it from damage. However, packaging of DNA
into chromatin is repressive towards DNA-templated processes
such as transcription [6]. Eukaryotic cells balance the needs to copy
and read, but simultaneously protect, genetic information through
a complex network of PTMs primarily directed toward the N- and
C-terminal tails of the four histones. Histone PTMs can alter the
charge of histones (e.g. lysine acetylation) and recruit speciﬁc
binding domains (e.g. acetylation, methylation, phosphorylation)
associated with proteins such as chromatin remodelers, transcrip-
tional coactivators/repressors, and DNA repair proteins. Histone
PTMs have gained prominence since the mid 1990s when the Allis
and Schreiber groups demonstrated that histone-modifying en-
zymes have direct roles in regulating gene expression [7,8]. The
sequencing of the human genome, development of chromatin
immunoprecipitation (ChIP), and next-generation sequencing
technologies have now made histone PTMs the best studied of all
cellular modiﬁcations. Just as there are a large number of PTMson the histone tails, there are also numerous protein domains that
recognize and bind to particular PTMs on these tails. For example,
PTM-recognition domains such as PHD (Plant homeodomain) ﬁn-
gers, chromodomains, and Tudor domains all recognize methylated
lysine residues, whereas bromodomains and 14-3-3 domains rec-
ognize acetylysine and phosphoserine/threonine respectively [9].
Most PTM-recognition domains recognize a particular modiﬁca-
tion within a deﬁned amino acid sequence, indicating that neigh-
boring amino acid sequence is important in the context of
substrate recognition by these proteins. Because histone tails are
rich in PTMs, the presence of nearby modiﬁcations inﬂuences the
ability of protein factors to recognize a particular PTM. For exam-
ple, phosphorylation of Ser10 on histone H3 (H3S10) negatively
inﬂuences HP1 (heterochromatin protein 1) recognition of methyl-
ation on neighboring Lys9 (H3K9) [10]. This phenomenon is re-
ferred to as the ‘‘phospho-methyl’’ switch, as H3S10
phosphorylation acts as a switch to prevent the binding of HP1
to chromatin in mitosis [10]. Recently, investigators uncovered
an exception to this ﬁnding, where the tandem Tudor domain of
UHRF1 binds to H3K9 methylation irrespective of the H3S10 phos-
phorylation state [11]. This ﬁnding suggests that multiple PTMs
can act in concert to carefully orchestrate the binding of numerous
factors to the same primary modiﬁcation. Similar examples have
been observed elsewhere on the H3 tail, where modiﬁcation at
either Arg2 or Thr3 can impact recognition of either neighboring
Lys4 methylation or the free N-terminus of histone H3 [12].
The example of the histone tails demonstrates that the inﬂu-
ence of neighboring PTMs on recognition likely extends far beyond
the few examples we have currently identiﬁed. Several groups re-
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ing PTMs have on the ability of antibodies to recognize histone
modiﬁcations [13–16]. In addition to illustrating important points
about how combinatorial PTMs mediate interactions, they also
highlight a need for great care in the development and implemen-
tation of reagents used to detect PTMs.
3. PTM codes are dynamic – the C-terminal domain (CTD) of
RNA polymerase and the ‘‘CTD code’’
In addition to the combinatorial nature of PTMs, the dynamics
between distinct codes play a prominent role in modulating bio-
logical function. The examples of combinatorial PTMs on histone
tails might lead to the assumption that patterns of modiﬁcations
are established and remain stable in the cell. While some histone
PTMs are quite long-lived, such as lysine methylation associated
with heterochromatin formation (H3K9 and H3K27 methylation)
[17], PTM patterns on histones and other proteins are often dy-
namic. Dynamics in PTM patterns is perhaps most apparent in
PTM changes to the C-terminal domain (CTD) of eukaryotic RNA
polymerase II (RNAPII) during transcription [18,19]. The CTD in
eukaryotic cells is comprised of a repeating seven amino acid se-
quence (Tyr-Ser-Pro-Thr-Ser-Pro-Ser) where all seven amino acids
within a repeat are subject to PTMs such as phosphorylation, O-
GlcNAcylation (addition of N-acetylglucosamine), and proline
isomerization [20]. As RNAPII transcribes DNA, the CTD adopts well
characterized changes in phosphorylation patterns. Ser5 phosphor-
ylation is most prevalent in RNAPII enzymes near the 50 end of
genes; Ser2 phosphorylation is most prevalent on RNAPII at the
30 end, while phosphorylation at both Ser2 and Ser5 is associated
with RNAPII in the middle of genes [20]. These PTM patterns are
established, and likely re-established, during every transcription
cycle by a carefully orchestrated network of kinases and phospha-
tases – serving to recruit speciﬁc factors to the CTD at distinct
times during the course of gene transcription. For example, phos-
phorylation of Ser5 of the CTD repeats by the Cdk7 kinase subunit
of TFIIH recruits the mRNA capping complex where it can act on
the nascent transcript [21]. Similarly, the histone-modifying en-
zyme Set2, which orchestrates histone methylation and acetylation
patterns important for transcription elongation, is recruited by the
combination of both Ser2 and Ser5 phosphorylation [22]. Recent
reports suggest that interactions with the CTD may not be limited
to just the combinatorial phosphorylation patterns. Indeed many
protein factors recognize the CTD in a manner that also depends
on the isomerization state of the Ser–Pro peptide bond [126,127].
While prolyl isomerases do not add a chemical moiety to the pro-
tein chain like kinases or methyltransferases, isomerization has a
profound effect on local peptide structure. This is evident in the re-
cent crystal structure of the phosphatase Ssu72, which only recog-
nizes its substrate (CTD with Ser5 phosphorylation) when the
Ser5–Pro6 is found in the cis-conformation [126]. As the cis-confor-
mation is the energetically disfavored state, isomerization of the
CTD (either uncatalyzed or catalyzed by prolyl isomerases) may
act as a timer to coordinate the recruitment of CTD-modifying
and associating factors [23].Deciphering the biological
function of PTM codes
 Approaches
Fig. 2. Relationships between experimental approaches and how they are used to
decipher the functions of PTM codes. Arrows are meant to designate the use of an
approach toward identifying PTMs, deﬁning coexisting PTMs, or deciphering
function. The thickness of each arrow represents the relative extent of
contributions.4. Patterns of PTMs are indicative of discrete functional states –
regulation of p53 by overlapping PTMs
As we learn more about the role of PTMs in protein regulation
and disease progression, we would like a set of rules that simplify
the potential functional outcomes of particular modiﬁcations. This
could lead to the identiﬁcation of biomarkers for particular dis-
eases (e.g. hyperphosphorylation of Tau associated with Alzhei-
mer’s disease [24]). However, discerning the contribution ofindividual modiﬁcations to protein regulation is complicated by
the dynamic and overlapping nature of PTMs. For example, the
C-terminal domain of the tumor suppressor protein p53 is subject
to numerous modiﬁcations (e.g. acetylation, methylation, ubiquiti-
nation, neddylation, phosphorylation). To further complicate the
situation, many modiﬁcations can occur on the same location
(e.g. acetylation, methylation and ubiquitination of at least four ly-
sines: 370, 372, 373, and 382. Under normal conditions p53 protein
is maintained at low levels in cells, mediated in part by ubiquitina-
tion at these lysines [25]. In response to stress, these lysines are
substrates of the acetyltransferase CBP/p300, which contributes
to stabilization of p53 and enhancement of DNA binding. More-
over, these same residues can be methylated, and neighboring ser-
ine/threonine residues can be phosphorylated – altering the
recruitment or speciﬁcity of enzymes such as CBP/p300.
5. Detecting and deciphering PTM codes
The study of combinatorial PTMs is driven by two fundamental
goals: one, the detection, mapping and quantitation of combinato-
rial PTMs; and two, deciphering the codes in which they partici-
pate to modulate biological function (Fig. 2).
Over the last 30 years, technological advances have dramati-
cally improved the sensitivity and dynamic range of non-radioac-
tive PTM detection methods. In the last two decades alone mass
spectrometry-based protein analysis has driven PTM research be-
yond the detection of single PTMs on individual proteins to the
simultaneous detection, localization and quantitation of thousands
of PTMs across entire proteomes and within hours of analysis time
[26]. Concomitant with advances in PTM detection there have been
notable improvements in technologies that decipher the biological
context of PTMs. Advancements in ﬂuorophore chemistry, ﬂuores-
cence spectrophotometry, peptide and antibody synthesis, and
microarray-based technologies enable rapid analysis of
PTM-dependent protein–protein interactions on a massively com-
binatorial scale. Further evolution of PTM research will undoubt-
edly beneﬁt from integrating detection and deciphering
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nature of PTMs. In the following sections, we discuss some of the
fundamental technological advances aimed toward detecting and
deciphering PTM codes.6. Analysis of PTM codes by mass spectrometry
The study of PTM codes begins with the detection and quantita-
tion of individual PTMs. Necessarily, the more PTMs that can be
accurately measured in a system, the more accurately a ‘‘code’’
may be deﬁned. Mass spectrometry (MS) has become the most
powerful analytical technique for detecting combinatorial PTMs
and relies on the integration of powerful instrumentation, sophis-
ticated data analysis, carefully chosen analytical strategy, and ap-
plied quantitative techniques. Successfully implementing these
four aspects is essential for detecting, mapping and quantifying
PTMs, and therefore PTM codes. Here we brieﬂy discuss some of
the fundamental parameters underlying MS analysis of combinato-
rial PTMs.
6.1. Instrumentation and data analysis
Mass spectrometry (MS), the process of measuring the mass of
charged particles, is accomplished by integration of three instru-
mental components: an ion source that generates gas phase molec-
ular ions; a mass analyzer that separates gas phase ions by their
mass-to-charge ratio (m/z); and an ion detector that registers the
number of molecular ions at each m/z value. The mass spectrome-
ter is unmatched as a bio-analytical tool – allowing one to measure
the mass of any given bio-molecule with extraordinary accuracy,
resolution, sensitivity, speed and reproducibility [27]. In addition
to accurate mass determination, today’s state-of-the-art mass
spectrometers enable the fragmentation of molecular ions by tan-
dem MS (MS/MS). MS/MS can provide valuable information about
the sequence and modiﬁcation state of proteins across a wide
range of masses from short peptides [28], to full-length intact pro-
teins [29–32].
MS/MS fragmentation plays a particularly important role in
identiﬁcation and localization of combinatorial PTMs. Peptide frag-
mentation mechanisms commonly used in PTM analysis include
collision-induced dissociation (CID) [33], electron-capture dissoci-
ation (ECD) [34] and electron-transfer dissociation (ETD) [35,36]. A
full discussion of the types and mechanisms of peptide and protein
fragmentation are outside the scope of this work, but have been re-
viewed elsewhere [37]. Regardless of mechanism, the challenge in
all cases is to create sufﬁcient fragmentation to accurately identify
the amino acid sequence of the precursor and to localize PTMs
within that sequence. A formidable hurdle for combinatorial PTM
research is the fact that certain types of PTMs are more amenable
to localization using certain types of fragmentation [38,39]. If a
peptide or protein is sufﬁciently fragmented and the PTMs are re-
tained, the location of the PTMs can be easily mapped by compar-
ing theoretical and observed fragment masses in silico. However,
labile PTMs like phosphorylation or glycosylation can be easily
‘‘lost’’ during CID fragmentation [40], making their site-speciﬁc
localization difﬁcult if not impossible. Moreover, fragmentation
can be effected by peptide length and charge state. Thus, alterna-
tive MS/MS fragmentation mechanisms such as ECD and ETD are
often necessary to improve the detection of combinatorial PTMs
[41,42]. Today, a variety of hybrid mass spectrometers enable mul-
tiple types of MS/MS – allowing one to tailor the fragmentation
method dynamically during a single experiment [43,44].
All aspects of protein MS have beneﬁted greatly from direct cou-
pling between the mass spectrometer and liquid chromatography
(LC) instrumentation. Indeed, detection sensitivity, MS/MSfragmentation and interpretation often improve if proteins and
peptides are adequately separated before MS [45]. Today, even
the most basic LC–MS/MS experiments can result in the detection
and quantitation of tens-of-thousands of distinct ions in the short
span of a standard LC gradient [46,47]. At the level of single pro-
teins, this translates to greater sequence coverage and the potential
for comprehensive PTM analysis. Moreover, multi-dimensional
chromatographic techniques now enable high-throughput and
comprehensive analysis of entire proteomes – allowing contextual,
systems-level analyses of nearly all proteins in a cell [48]. LC–MS is
now the predominant method for detecting and quantifying the
dynamics of combinatorial PTM codes as can be seen from its exten-
sive application to the study of the histone ‘‘code’’ [49–51], the
tubulin ‘‘code’’ [52–54], and p53 PTMs [55].
Extrapolating biological signiﬁcance fromMS data requires soft-
ware-based integration of MS instrument platforms, analysis
strategies (e.g. top down versus bottom up), and online databases
[56–58]. Ironically, MS data analysis in the proteomics age is only
possible because of advances in genomics. Complete genome se-
quences for organisms across all kingdoms have enabled the predic-
tion of theoretical protein and peptide masses that are essential for
interpreting MS and MS/MS spectra. Identifying PTMs, in turn, re-
lies on accuratemassmeasurement and the search for distinctmass
signatures corresponding to any one of >400 different protein mod-
iﬁcations. A PTM ‘‘code’’ may be deﬁned by very small chemical or
spatial differences such as acetylation versus tri-methylation of ly-
sine (Dm/z < 2 Da), or by the presence of phosphorylation on juxta-
posed serine residues (e.g. phosphorylation of serine 4 and 9 but not
serine 6 and 7 within a single peptide). Accurately detecting these
subtle differences in mass and PTM localization is paramount to
the process of deﬁning a PTM ‘‘code’’ and remains an important
problem. Accurate data analysis not only relies on accurate mass
and optimalMS/MS fragmentation, but also on the precise interpre-
tation ofMS andMS/MS data [59–61]. Bioinformatics software tools
are readily available and offer many options to streamline the con-
version of MS spectra into meaningful biological information. The
purpose of these tools is to place statistical signiﬁcance on the iden-
tity and location of PTMs based on the compilation of intact precur-
sor and fragment masses in an MS/MS spectrum [57,62]. This is not
trivial because different proteins can sometimes produce similar
peptides that produce identical MS/MS fragmentation patterns.
Furthermore, increasing the complexity of the sample necessarily
increases the stringency required to meet these challenges. Conse-
quently, with the throughput of today’s MS instrumentation, MS
data analysis software is critical for assigning a value to MS data
integrity [63–65].
6.2. Analytical strategies
Choosing an appropriate analytical strategy is paramount to the
detection of PTMs and PTM codes, and is intimately coupled with
instrumentation and data analysis. Whether deciphering PTM
codes on histone tails, tubulin, RNA polymerase, or p53, the over-
arching goal in every case is to maximize protein ‘‘coverage’’ by
monitoring every amino acid and PTM on the protein – a formida-
ble ‘‘selective pressure’’ in the evolution of analytical methodolo-
gies [66]. Three complementary analytical strategies have proven
successful: bottom-up, top-down and middle-down. In the bot-
tom-up strategy, proteins of interest are ﬁrst digested with site-
speciﬁc proteases and the resulting peptides are analyzed by MS.
In the top-down strategy, full-length intact proteins are analyzed
byMS followed by iterations of MS/MS fragmentation that yield se-
quence and PTM information. In the middle-down strategy, pro-
teins are broken down enzymatically into large peptide
fragments that fall between the mass range of either bottom-up
or top-down strategies. Each strategy has some demonstrated
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inherent challenges.
To date, bottom-up MS is the most commonly used approach in
proteomics. Fundamentally, the bottom-up strategy may be con-
strued as counter productive for the detection of PTM codes since
the strategy relies on proteolytic digestion a priori, and therefore
un-couples the combinatorial relationship between distant PTMs
on whole proteins. However, the strategy is overwhelmingly pop-
ular because it can be applied with relative ease to detect peptides
and interpret their fragmentation by MS/MS. In combination with
2-dimensional LC techniques, the bottom-up strategy has proven
to be successful at detecting thousands of proteins present in a sin-
gle sample [47]. Furthermore, comprehensive analysis of PTM-spe-
ciﬁc sub-populations of the proteome such as the
‘‘phosphoproteome’’, the ‘‘ubiquitinome’’, the ‘‘acetylome’’ and
the ‘‘methylome’’ are facilitated by afﬁnity-based PTM-enrichment
methods [67–71]. Despite this seemingly unmatchable advantage,
what the bottom-up strategy gains in breadth of analysis, it lacks in
depth of analysis. Indeed, bottom-up proteome-wide LC–MS
experiments often detect as few as 1–2 peptides per protein, which
is sufﬁcient for protein identiﬁcation but not ideal for the detection
of combinatorial PTM codes. Moreover, afﬁnity enrichment of spe-
ciﬁc PTMs necessarily excludes non-enriched PTMs, which may be
important in the deﬁnition of a PTM ‘‘code’’ [66]. In contrast, tar-
geted bottom-up MS approaches, in which proteins of interest are
enriched prior to MS analysis, are more effective for detecting
PTM codes on single proteins. This is effectively demonstrated in
the recent work of Garcia and Reinberg [72], who use bottom-up
MS to quantify the co-enrichment of histone tail PTMs. By enrich-
ing nucleosomes with antibodies to distinct histone tail modiﬁca-
tions, Voigt et al. not only detect intra-tail PTMs but also provide
convincing evidence of the asymmetrical modiﬁcation between
the two ‘sister’ tails of a single nucleosome (discussed further in
section 9). Targeted approaches such as this are not unique to his-
tones and have also been widely used in the study of combinatorial
PTMs on multi-protein complexes. Prevalent examples include the
analysis of combinatorial phosphorylation patterns underlying the
cell cycle-dependent activity of ubiquitin ligases [73–75], the cen-
trosome [76] and the mitotic spindle assembly [77]. These, among
many other examples, establish targeted bottom-up MS as an
advantageous strategy for the detection of PTM codes.
Top-down MS is the predominant alternative to the bottom-up
strategy. In top-down, MS and MS/MS are conducted directly on in-
tact proteins (from 8E3 Da to 2E6 Da) without proteolytic digestion
[78]. As a result, information on the combinatorial nature of PTMs
on single proteins is retained. Top-downMS is generally performed
on ion-trap spectrometers with ETD or ECD capability. Ion trapping
permits iterative cycles of MS/MS (aka MSn) fragmentation and
mass analysis, consequently allowing detection of intact protein
or protein fragments. A typical top-down MS experiment begins
with accurate mass determination (MS), followed by primary frag-
mentation and fragment mass analysis (MS2), then isolation of a
single MS2 fragment that is broken down even further in a subse-
quent MS/MS reaction (MS3) – all within the duration of a single
injection [32]. Thus, sources of variation in the intact protein mass
(often corresponding to PTMs) can be rapidly mapped to speciﬁc
domains or amino acids within the primary structure. The
top-down strategy is particularly amenable to detection of combi-
natorial PTM codes on single proteins like tubulin [32], p53 [79],
histones [80–82] and G-protein coupled receptors [3]. The
top-down strategy exhibits several advantages over bottom-up ap-
proaches for the detection of PTM codes [29,83]. First, determining
intact protein mass provides comprehensive information on the
global modiﬁcation state of a protein. Second, unlike the bottom
up strategy, the presence of PTMs tends to have less effect on the
ionization/detection efﬁciency of intact proteins. Third, intactprotein analysis is not restricted to the position of enzymatic cleav-
age sites in a protein. In contrast, analysis of intact proteins is gen-
erally less sensitive compared to the detection of peptides.
Furthermore, successful detection of intact proteins is extremely
sensitive to the protein solvent as well as the protein sequence,
increasing variability in the success rate from protein to protein.
Middle-downMS is an emerging analytical strategy that focuses
on the mass range between that of the top-down and bottom-up
approaches (4000–10,000 Da). Middle down MS capitalizes on
the relative ease and reproducibility of detecting smaller proteins
without losing too much ‘‘whole-protein’’ context that is afforded
by top-down MS [78]. Proteins are typically digested to a limited
extent or with alternative enzymes that have limited recognition
sites in a target protein. The major challenge in middle-down MS
is the precise and reproducible control of limited digestion or in
ﬁnding compatible enzymes that have few recognition sites in
the target protein. A recent breakthrough in the Kelleher lab may
turn out to bring middle-down MS to the forefront of PTM ‘‘code’’
research [84]. In their recent report, Wu et al. uses a novel protease
from Escherichia coli (OmpT) that cleaves proteins at recognition
sites with two consecutive basic residues (e.g. R–R, K–K, R–K, or
K–R). The relative frequency of the OmpT recognition sequence is
low compared to traditional proteases – yielding fewer peptides
of much larger size that are ideal for middle-down MS analysis.
The disadvantage may lie in the fact that lysine and arginine are
common targets of post-translational modiﬁcation, which would
effectively prevent cleavage by OmpT. Regardless, enzymes like
OmpT may catapult middle-down MS into the throughput equiva-
lence of current bottom-up strategies for the detection of combina-
torial PTMs and PTM codes.
6.3. Quantitation
Simply detecting a group of PTMs reveals little information
about their combinatorial function. Indeed, quantifying the
dynamics of combinatorial PTMs is essential to deﬁning a relation-
ship between PTM codes and biological outcome [49]. Mass spec-
trometry is not inherently quantitative. Thus, multiple peptide
and PTM quantitation strategies have emerged including stable
isotope labeling (SIL), and label-free methods such as selected
reaction monitoring (SRM), among others reviewed elsewhere
[85,86]. SIL capitalizes on the high resolution of mass spectrome-
ters by using heavy isotope mass tags to distinguish the relative
concentrations of a mixture of identical peptides. Importantly sta-
ble isotope labeling does not alter the amino acid composition nor
the modiﬁcation state of peptides. As a result, MS signals from iso-
tope labeled and unlabeled peptides can be directly compared and
quantiﬁed from the mass spectrum. Two predominant methods of
stable isotope labeling have been established: incorporation of tags
in vivo using stable isotope labeling with amino acids in cell culture
(SILAC) [87], or covalent attachment of tags in vitro using iTRAQ or
alternative chemical tags that typically modify primary amine or
free thiol reactive groups [88]. Many label-free approaches to MS
quantitation are also gaining prominence and are often more eco-
nomical than SIL. SRM in particular, provides an instrumental ap-
proach to quantitation that avoids the need for additional sample
processing [89,90]. In a more diagnostic approach, stable isotope-
labeled peptide or protein standards can be used to repetitively
quantify pre-deﬁned or known groups of modiﬁcations, such as
would be found in a discrete signaling pathway [91–93].
Despite the rapid co-evolution of MS instrumentation, data
analysis, analytical and quantitative strategy, no one combination
of MS methods yields all the answers. Indeed, MS-based PTM
detection might best be thought of like a Venn diagram in which
each combination of techniques covers both overlapping and
unique discovery space. Furthermore, some of the strategies
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yet evolved to a state in which non-experts can access and/or eas-
ily apply the methods. In fact, ﬁnancial or scientiﬁc barriers often
hinder connections between MS technology and meaningful bio-
logical research. Thus, the development of unifying MS approaches
as well as improving their accessibility and ease of use for biolo-
gists represents a major challenge for the future study of combina-
torial PTMs and the codes that they comprise.
7. Assessing combinatorial PTMs using peptide libraries
Investigation of the biochemical function of PTMs has been
greatly advanced with the use of synthetic chemistry, where types
and locations of PTMs can be precisely deﬁned. Studies of combina-
torial PTMs have therefore been greatly facilitated by the creation
of peptide libraries, which incorporate any desired combination of
modiﬁed amino acid residues during synthesis. Many modiﬁed
amino acid derivatives that are compatible with peptide synthesis
are commercially available (such as phosphoserine or methyllysine
derivatives). Furthermore, non-natural chemical analogs enable
the biochemical and biophysical examination of PTMs which are
either transient or unstable,such as the use of isosteres to investi-
gate cis–trans isomerization of proline [94]). Thus, through
solid-phase peptide synthesis (SPPS), large libraries of peptides
containing PTMs at speciﬁc locations can be synthesized. Pairing
organic synthesis with high-throughput detection approaches al-
lows one to quickly, and simultaneously probe hundreds to thou-
sands of interactions.
Studies with PTM-containing peptides have been bolstered by
the development of surface-based microarrays. Peptide arrays in-
volve the deposition of chemically synthesized peptides onto a
medium (membrane or glass slide) in small spots, where the
immobilized peptides are used in high-throughput parallel assay
format to examine many aspects of protein function including
binding and enzymatic activity. Two main types of peptide arrays
dominate the ﬁeld – in situ arrays, such as SPOT arrays, where pep-
tides are directly synthesized on membranes, and spotted peptide
arrays where pre-synthesized, puriﬁed peptides are deposited by a
robotic microarrayer [95,96]. Spotted peptide arrays use SPPS to
create a deﬁned quantity of a peptide affording excellent quality
control over the peptides being tested. Furthermore, each peptide
in the library can be synthesized on a scale large enough for hun-
dreds of individual arrays yielding great reproducibility. Further-
more, as peptides are commonly immobilized through a
prosthetic biotin group onto a streptavidin-coated surface, the dis-
play of peptides is largely uniform. In contrast to spotted peptide
arrays, in situ arrays such as SPOT arrays, developed in the early
1990s, synthesize molecules directly on a cellulose membrane.
SPOT methods can be created quickly – with no separate on-resin
synthesis, cleavage steps, peptide puriﬁcation, or immobilization
steps [97]. This makes a greater diversity of arrayed peptides easier
to achieve with SPOT arrays. However, SPOT arrays do not allow
analytical analysis of each peptide once its synthesized, and as
each array is essentially unique, there is often signiﬁcant variabil-
ity between experiments. Peptide microarrays have been used to
great effect in studying the combinatorial effects of histone PTMs
[13,14,98]. They have also been used to determine the speciﬁcity
and activity of enzymes that add PTMs, such as kinases and meth-
yltransferases [99,100]. Advances in supports, such as the use of
silicon wafers, suggest that the power of these technologies could
be greatly expanded by integrating circuits and measuring interac-
tions in real-time [100].
Peptide library-based approaches to combinatorial PTMs are
not merely limited to array-based experiments. Solution-phase,
‘‘one bead one compound’’ libraries enable the simultaneous studyof a large number of interactions. Brieﬂy, peptides containing PTMs
of interest remain bound to individual resin beads. In this method,
very large numbers of randomly sequenced peptides can be cre-
ated by splitting the total resin and coupling each of the split
batches to different amino acids, then mixing the variously coupled
resin beads back together in one pool to generate large, diverse
peptide libraries [101]. Binding studies or enzymatic reactions
are then carried out on the entirety of the bead pool, ensuring that
every peptide in the library is sampled. The advantage of solution-
phase libraries is the ability to create and probe peptide libraries
with thousands of unique members. This method has been used
with great success to measure the inﬂuence of individual amino
acid positions on the binding of histone PTMs [102,103].
Generally, peptide library approaches rapidly provide a wealth
of information about how varying types of PTMs affect binding
interactions or enzymatic activities. However these methods do
not provide quantitative data. Therefore, initial results from high-
throughput approaches are commonly paired with additional bio-
physical experiments aimed at further scrutinizing interactions de-
tected on the arrays or bead libraries. Techniques such as surface
plasmon resonance (SPR), calorimetry, or ﬂuorescence polarization
give detailed, quantitative information such as the binding con-
stant for interactions of signiﬁcance.
Since the description of the ‘‘histone code hypothesis’’ [2], many
experiments have focused on determining how the pattern of his-
tone PTMs regulate their function and modulate chromatin. Bio-
physical and structural studies are key to ultimately
understanding the molecular nature of the interactions between
protein readers and PTMs [104]. However, the vast number of po-
tential histone modiﬁcations renders a library approach very effec-
tive towards initial investigation of histone-interacting proteins
and antibodies. For example a library of over 100 histone peptides,
containing up to seven PTMs on a single peptide, was tested
against domains of histone interacting proteins and PTM-speciﬁc
antibodies to determine speciﬁcity [13]. This study deﬁned impor-
tant problems with PTM-speciﬁc antibodies – notably that they are
strongly inﬂuenced by neighboring PTMs and can recognize PTMs
in a sequence non-speciﬁc manner. This has been reinforced by
several similar studies [15,105]. More recently, similar arrays were
used to uncover an unusual combinatorial modiﬁcation that con-
trols the maintenance of DNA methylation by UHRF1, which must
associate with a methylated lysine of histone H3 to carry out this
activity [11]. A combinatorial aspect of this inquiry focused on
the inﬂuence of a neighboring phospho-serine residue, which
was found not to impact the recruitment of UHRF1 to chromatin
but did evict other protein factors known to recognize the same
methyllysine mark [11]. Using SPOT, Ruthenburg and colleagues
demonstrated the impact of combinatorial histone modiﬁcations
on the binding of different domains of a NURF chromatin remodel-
ing complex subunit [106]. This study used arrays to examine
whether the PHD ﬁnger and adjacent bromodomain of the NURF
subunit acted in concert to bind histone tails. SPOT arrays have also
effectively been used to examine the speciﬁcity of enzymes. For
example, Rather et al. used SPOT arrays to determine the binding
sequence for the G9a methyltransferase, which then allowed them
to make different arrays of potential target peptides to uncover
new non-histone substrates for G9a [107]. Array and bead based li-
braries have been utilized to deﬁne an unusual binding pattern for
the plant homeodomain ﬁngers of CHD5, which recognizes an
unmodiﬁed H3 N-terminal tail, and is disrupted by several types
of PTMs on the N-terminal tail [108]. In contrast, the ‘‘one bead
one compound’’ approach was used to produce 800-member and
5000-member combinatorial libraries which demonstrated clear
preferences among N-terminal PTMs on histone H3 and H4 for
the binding of speciﬁc protein factors [102,103].
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study of combinatorial PTMs will only continue to expand. The va-
lue and effectiveness of arrays and bead libraries in examining
combinatorial (as opposed to single) PTMs of proteins has yet to
be fully realized. The technology itself is also still evolving; the sil-
icon chip support of the recently developed ‘‘Intel arrays’’ [100]
provides an exciting new avenue of potential real-time reporting
of data from peptide arrays. Furthermore, the pool of reagents for
solid-phase peptide synthesis is continually expanding, which
leads to a direct increase in the diversity possible within libraries.
PTM-containing peptide libraries hold great promise toward the
development of detection reagents such as antibodies or to study
how small molecules selectively disrupt protein–protein interac-
tions mediated by PTMs.
8. Importance of PTM-speciﬁc antibodies
We have primarily focused on methods for the de novo detection
of combinatorial PTMs or techniques to decipher their roles on protein
binding or catalytic activity. Not to be overlooked is the prominent
role that PTM-speciﬁc antibodies play in identifying relative changes
in PTM patterns both in cells and in vitro. In fact, PTM-speciﬁc anti-
bodies have become so commonplace that antibodies for nearly any
biologically-important modiﬁcation are now commercially available.
For example, more than 1000 PTM-speciﬁc antibodies are commer-
cially available for just the four core histones alone. PTM codes will
likely have an impact on the utility, reliability, and speciﬁcity of these
antibodies. Thus steps should be taken to develop better tools for
antibody veriﬁcation, as well as new diagnostic tools, which can dis-
tinguish or identify important instances wheremultiple PTMsmay be
coordinately regulating a single protein.
Antibodies for the study of combinatorial modiﬁcations were
amongst the ﬁrst PTM-speciﬁc antibodies developed. For example,
antibodies were critical to identifying hyperphosphorylated forms
of RNA polymerase II [109]. Similarly, Allis and coworkers used
antibodies against polyacetylated histone H4 to decipher the role
of histone acetylation in transcriptional regulation [110]. Today
these poly-speciﬁc antibodies are still used to identify heteroge-
neous biomarkers such as hyperphosphorylated tau or activated
(hyperphosphorylated) p53, but these tools are being slowly re-
placed by other, more-speciﬁc PTM-directed detection reagents.
In the early 1980s researchers began to develop antibodies to
speciﬁcally identify modiﬁed forms of proteins [111]. Antibodies
have high speciﬁcity for their antigen, thus PTM-speciﬁc antibodies
are widely used to detect speciﬁc modiﬁcations on proteins by
Western blots or immunohistochemical methods. Because of their
high afﬁnity, PTM-speciﬁc antibodies have also been widely used
to immuno-enrich/deplete formodiﬁed proteins. This is often a pre-
liminary step to mass spectrometry analysis when trying to isolate
a particular protein or protein variant. PTM-speciﬁc antibodies have
also played a central role in our understanding how histone PTMs
mark regions of the genome through the use of chromatin immuno-
precipitation (ChIP). Brieﬂy protein–DNA interactions are stabilized
by crosslinking with formaldehyde, chromatin is sheared into small
pieces to facilitate analysis, and samples are immune-enriched
using an antibody raised against a protein (or PTM) of interest. Fol-
lowing enrichment, the crosslinks are reversed to free the DNA,
which is then quantiﬁed to measure the relative amount of the pro-
tein associated with different regions of the genome. Through ChIP,
researchers were able to identify histone PTMs associated with pro-
moter regions, silenced regions of the genome, and even different
regions within transcribing genes [112]. The advent of DNA micro-
array and next-generation sequencing technologies made it possi-
ble to map the relative levels of dozens of histone PTMs to every
region of multiple genomes.Several key papers in the past few years have pointed out sev-
eral important shortcomings of PTM-speciﬁc antibodies. Fuchs
et al. showed using peptide microarrays that antibodies directed
against methyllysine on histones were generally sequence speciﬁc
but had difﬁculty distinguishing between different levels of meth-
ylation (mono-, di-, and trimethyl) [13]. This has considerable im-
pact on studies of histone methylation. For example, di- and
trimethylation at both histone H3 Lys4 and Lys36 are thought to
have opposing roles in transcriptional regulation in yeast (dime-
thylation is thought to be repressive where trimethylation is acti-
vating) [113,114]. Thus, cross-reactivity of antibodies may
obfuscate meaningful changes in histone methylation in cells, or
at a particular locus. This is not only true for histone PTMs but
for other important signaling events as well [115]. Several studies
have now shown that acetyllysine antibodies are generally promis-
cuous – recognizing a variety of acetyllysine-containing peptides
[13,14,16]. Rothbart et al. took this a step further demonstrating
that this promiscuity occurs within cells making ChIP analysis of
single acetylation marks on histone H4 likely impossible [16]. A
large survey conducted by the ModEncode consortium tested a
number of commercially-available histone antibodies and noted
the failure of many in at least one common biochemical assay
[15]. Highly-modiﬁed peptide arrays were also able to demon-
strate that antibodies were highly inﬂuenced by neighboring PTMs.
For example, recognition of phosphorylation at Histone H3 Ser10
(H3S10) was largely blocked by methylation or acetylation at
neighboring Lys9 for an antibody raised to recognize H3S10 phos-
phorylation. Thus in a cell population, instances where these marks
coexist would be normally overlooked. However, H3K9 trimethyla-
tion and H3S10 phosphorylation do coexist in cells [10] and its
relevance for the targeted recruitment of the DNA-methylation-
associated protein UHRF1 [11]. Lastly, as most PTM-speciﬁc
antibodies are polyclonal, they are an exhaustible resource and dif-
ferent lots show distinct proﬁles [13,15,105]. This often makes
ﬁnding the proper antibody for an experiment a laborious task.
All these factors together suggest a strong need for improved
PTM-speciﬁc antibodies or the development of alternative detec-
tion reagents.
The next few years should bring an even greater variety of detec-
tion technologies with a push toward monoclonal antibodies that
recognize biologically important PTMs and the evolution of new,
non-immunoglobulin-based scaffolds. For example, many mono-
clonal antibodies are now available for the study of histones. These
reagents solve a problem of renewability, demand, and reproduc-
ibly. However, a monoclonal antibody recognizes its target in only
one way. Thus, monoclonal antibodies may be hypothesized to be
more affected by neighboring PTMs than polyclonal antibodies,
which bind to a peptide substrate more heterogeneously. Several
protein scaffolds have been designed which recognize PTMs. New
scaffolds have considerable advantages as they can be expressed
recombinantly and puriﬁed in high quantity. However, these pro-
tein scaffolds do not generally bind with the same afﬁnity afforded
by antibodies, and they too will likely be strongly inﬂuenced by
neighboring PTMs. In instances where multiple PTMs are known
to be important for a biological process dual-speciﬁc antibodies or
alternative scaffolds might have great success. Dual-modiﬁcation
antibodies that recognize histone tails have exquisite speciﬁcity
for example [13]. Nonetheless, thorough studies of complex neigh-
boring PTMs, may require numerous antibodies to recognize all the
combinations of PTMs that may be relevant in vivo.
9. Moving beyond single protein codes
We have highlighted a few demonstrative examples of how
PTMs function in concert to regulate biological function. Our cur-
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Fig. 3. PTM codes can exist at varying levels of biological complexity. Two distinct
outcomes (State 1 and 2) can be deﬁned for simple linear PTM codes (top), a protein
complex (middle), or a functional network consisting of several proteins acting
coordinately (bottom). In all cases, differing patterns of PTMs on one or more
proteins give rise to discrete biological outcomes.
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teins, whereby direct relationships between PTMs and protein
structure and function can be evaluated through traditional molec-
ular biology and biochemical methods. These types of experiments
have revealed many different ways in which PTMs can alter the
structure and function of a protein by manifesting changes in con-
formation, recruitment of binding proteins or through direct ef-
fects on catalytic activity. Over the last few decades, increasingly
sophisticated and robust MS-based methods have uncovered a
plethora of PTM types. In parallel, a wide array of biochemical
studies has identiﬁed a growing list of protein domains that
speciﬁcally recognize some of these modiﬁcations. The examples
discussed here exemplify a common theme in which PTMs on
un-structured protein segments regulate protein interaction land-
scapes – the array of potential protein–protein interactions that
can exist for a protein. Changes to this landscape directly affect
the assembly of protein complexes resulting in differential func-
tional output of the modiﬁed protein. This hypothesis has emerged
in large part due to discoveries made in support of the histone code
hypothesis [116], which states that differential PTM combinations
coordinate the assembly of proteins that regulate gene transcrip-
tion. Similar examples include the CTD of RNA polymerase II,
tubulin and p53. In all cases, the overriding hypothesis is that com-
binations of PTMs that can be shown to create functionally distinct
interaction landscapes can be deﬁned as a ‘‘code’’. Within this par-
adigm, biological processes are regulated in part by PTM codes that
modulate protein interaction landscapes, and therefore function, of
any given protein.
Emerging and longstanding evidence suggests that PTM codes
can extend beyond single proteins. Protein interaction landscapes
very likely emerge from the interplay between multiple layers of
PTM coordination. That is to say that PTM ‘‘codes’’ can coordinate
groups of proteins such as those found within a multi-protein com-
plex (Fig. 3). The hypothesis in this case is that the function of a
multi-protein complex can be modulated by differential combina-
torial codes that exist betweenmembers (subunits) of the complex.
A notable example is the observation that intra-nucleosomal his-
tonemodiﬁcations can inﬂuence eachother. For example, H2B ubiq-
uitination at Lys123 can inﬂuence the methyltransferases that
modify Lys4 and Lys79 on Histone H3 [117]. More recently, Ruthen-
berg et al. demonstrate that methylation on Histone H3 and acety-
lation on Histone H4 at Lys16 both were responsible for the proper
association of the tandem PHD–Bromodomain of BPTF [106]. In
addition, experiments conducted by the Reinberg and Garcia labs
(described in section 5) provide an excellent example of how we
might begin to think about how PTM codes can be deciphered for
multi-protein complexes [72]. Indeed, their work demonstrates
that PTM codes extend beyond single proteins (like histone tails)
and towards a combinatorial interaction between PTMs acrossmul-
tiple proteins or subunits. Thus, in addition to the histone code, one
might also consider the possibility of a nucleosome code where
combinatorial PTMs, both in cis and in trans, contribute to the
recruitment of protein factors and changes in chromatin structure.
Whereas the histone code dictates protein assembly onto a single
histone tail, a nucleosome code might dictate the organization of
histones with respect to one another inside a mono-nucleosome.
The concept that combinatorial PTMs modulate function of multi-
protein complexes is not restricted to histones [118]. For instance,
dynamic phosphorylation of multi-subunit ubiquitin ligases such
as the anaphase-promoting complex is essential for cell cycle-regu-
lated substrate speciﬁcity [74,75,119]. Deciphering PTM codes in
these cases has proven difﬁcult, due in part to the signiﬁcant chal-
lenge of integrating both detection and deciphering approaches
into one study. However, if technological improvements can ad-
dress this challenge, dynamic signaling complexes may represent
an ideal model for the study PTM codes.Yet another layer of PTM regulation that extends beyond protein
complexes has been discovered for histone code ‘‘readers’’ – pro-
teins whose assembly on histone tails is dynamically regulated by
combinatorial PTMs. Recent efforts by the Cairns lab has shown that
PTMs on the chromatin remodeling complex, RSC, can impact
nucleosome structure and function [120]. RSC speciﬁcally recog-
nizes histone H3K14 acetylation through tandem bromodomains,
and is essential for mitotic growth in yeast. Acetylation of K25 on
the RSC subunit, Rsc4, results in auto-recognition by RSC through
one of its bromodomains, leading to competitive inhibition of
RSC/histone association. Thus, just as PTMs on the tails of histone
H3 can affect nucleosome structure and function, so can PTMs that
appear on histone-associated protein readers such as RSC.
10. Perspectives and future challenges
Our understanding of how concerted PTMs coordinate biologi-
cal function is in its infancy. We are beginning to understand
how combinations of PTMs can affect structure and function of sin-
gle proteins through experiments with histones and other exam-
ples described in this review. However, the story is far from over.
Emerging evidence suggests that PTM ‘‘codes’’ (in as much as a
‘‘code’’ or combination of PTMs is deﬁned by its necessity in a func-
tional process) extend beyond the level of a single-protein. We
have put forth cases in which concerted PTMs coordinate members
of a protein complex (e.g. histones within mono-nucleosomes and
multi-subunit ubiquitin ligases) as well as members of a concerted
function (e.g. histone code readers like RSC). What is learned from
simple systems will hopefully reveal fundamental concepts
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ger scale. The major question within this assumption is whether
sites of protein modiﬁcation, which in isolation are not commonly
conserved evolutionarily, might contribute to a functional PTM
network that is well conserved. Recent studies in computational
systems biology have begun to address these assumptions by eval-
uating the co-evolution of PTMs based on co-occurrence of modiﬁ-
cation sites across multiple different eukaryotes [121]. The
computational results of this work suggest the existence of a global
network of co-evolving PTMs that impinge on multiple functional
states of many proteins. In fact, PTMs and their maintenance
through natural selection may best be understood in the context
of functional networks in which they participate rather than in
isolation.
With the seemingly boundless amounts of data emerging from
MS-based PTM studies, deciphering functional PTM codes will
likely beneﬁt from systems-level analyses and network theory,
which become increasingly useful with further integration of pro-
teomic technology and combinatorial biophysical assays. Indeed,
many efforts have already begun to utilize quantitative proteomic
approaches to decipher functional PTM networks in the context of
human disease and therapy [122–125]. Ideally, there will come a
day when one can evaluate any PTM on any protein with regards
to its contribution to any given PTM network and biological
process.
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